{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:52:26Z","timestamp":1791147146072,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1124\/mol.63.3.678","type":"journal-article","created":{"date-parts":[[2003,2,27]],"date-time":"2003-02-27T18:30:53Z","timestamp":1046370653000},"page":"678-681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Increased Antiviral Activity of 1-O-Hexadecyloxypropyl-[2-14C]cidofovir in MRC-5 Human Lung Fibroblasts Is Explained by Unique Cellular Uptake and Metabolism"],"prefix":"10.1016","volume":"63","author":[{"given":"Kathy A","family":"Aldern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L","family":"Ciesla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine L","family":"Winegarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Y","family":"Hostetler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.63.3.678_bib1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0026-895X(25)08630-4","article-title":"Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates","volume":"47","author":"Aduma","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.63.3.678_bib2","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1128\/AAC.46.8.2381-2386.2002","article-title":"Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple log enhancement of antiviral activity against cytomegalovirus and herpes virus replication in vitro.","volume":"46","author":"Beadle","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.63.3.678_bib3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/15257770008033022","article-title":"Synthesis and antiviral evaluation of 1-O-hexadecylpropanediol-3-P-acyclovir: efficacy against HSV-1 infection in mice","volume":"19","author":"Beadle","year":"2000","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1124\/mol.63.3.678_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1086\/315190","article-title":"Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge","volume":"181","author":"Bray","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1124\/mol.63.3.678_bib5","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/0006-2952(93)90670-R","article-title":"Mechanism of uptake of the phosphonate analog (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in Vero cells","volume":"46","author":"Connelly","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.63.3.678_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000150563","article-title":"Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections","volume":"40","author":"De Clercq","year":"1997","journal-title":"Intervirology"},{"key":"10.1124\/mol.63.3.678_bib7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0166-3542(87)80004-9","article-title":"Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines","volume":"8","author":"De Clercq","year":"1987","journal-title":"Antivir Res"},{"key":"10.1124\/mol.63.3.678_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0026-895X(25)08828-5","article-title":"Intracellular metabolism of the antiherpes agent (S)-1[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine","volume":"41","author":"Ho","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.63.3.678_bib9","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1128\/AAC.44.7.1964-1969.2000","article-title":"Antiviral activities of oral 1-O-hexadecylpropanediol-3-phospho-acyclovir and acyclovir in woodchucks with chronic woodchuck hepatitis virus infection","volume":"44","author":"Hostetler","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.63.3.678_bib10","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0006-2952(97)82446-X","article-title":"Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro.","volume":"53","author":"Hostetler","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.63.3.678_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/095632020101200104","article-title":"In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections","volume":"12","author":"Hostetler","year":"2001","journal-title":"Antiviral Chem Chemother"},{"key":"10.1124\/mol.63.3.678_bib12","first-page":"A66","article-title":"Orally active ether lipid prodrugs of cidofovir for the treatment of smallpox (Abstract)","volume":"53","author":"Huggins","year":"2002","journal-title":"Antivir Res"},{"key":"10.1124\/mol.63.3.678_bib13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/AAC.46.4.991-995.2002","article-title":"Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir","volume":"46","author":"Kern","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.63.3.678_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00003495-199652020-00006","article-title":"Cidofovir","volume":"52","author":"Lea","year":"1996","journal-title":"Drugs"},{"key":"10.1124\/mol.63.3.678_bib15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jmv.1890410312","article-title":"Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice","volume":"1993 41","author":"Neyts","year":"1993","journal-title":"J Med Virol"},{"key":"10.1124\/mol.63.3.678_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00003495-199958020-00015","article-title":"Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS","volume":"58","author":"Plosker","year":"1999","journal-title":"Drugs"},{"key":"10.1124\/mol.63.3.678_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/095632020101200105","article-title":"Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir","volume":"12","author":"Smee","year":"2001","journal-title":"Antivir Chem Chemother"},{"key":"10.1124\/mol.63.3.678_bib18","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1128\/AAC.32.12.1839","article-title":"(S)-1-(3-Hydroxy-2-phos-phonomethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication","volume":"32","author":"Snoeck","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.63.3.678_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/(SICI)1096-9071(199803)54:3<219::AID-JMV13>3.0.CO;2-C","article-title":"Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]","volume":"54","author":"Snoeck","year":"1998","journal-title":"J Med Virol"},{"key":"10.1124\/mol.63.3.678_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jmv.2213","article-title":"Local treatment of HPV-induced skin lesions by cidofovir","volume":"67","author":"Stragier","year":"2002","journal-title":"J Med Virol"},{"key":"10.1124\/mol.63.3.678_bib21","first-page":"3","article-title":"A review of topical and intralesional cidofovir","volume":"6","author":"Zabawski","year":"2000","journal-title":"Dermatol Online J"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24057687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24057687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.63.3.678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T08:52:08Z","timestamp":1740041528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24057687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0026895X24057687"],"URL":"https:\/\/doi.org\/10.1124\/mol.63.3.678","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Antiviral Activity of 1-O-Hexadecyloxypropyl-[2-14C]cidofovir in MRC-5 Human Lung Fibroblasts Is Explained by Unique Cellular Uptake and Metabolism","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.63.3.678","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}